← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Cyanocobalamine currently has availability issues reported in 2 European registers: France, Italy.
Shortage ATC — · also listed as: cyanocobalamine · CIANOCOBALAMINA · data refreshed 8 September 2026
As of 8 September 2026, 2 of the 9 tracked registers list current availability issues for Cyanocobalamine, covering 4 affected product presentations. The longest-running open report was filed in Italy on 2024-12-31 and has now been open for about 21 months. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 2 stated-cause reports, followed by manufacturing problems with 1. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇫🇷 France | Limited availability Vitamine B12 Delagrange 1000 µg/2 ml, solution injectable (IM) et buvable + 1 more productsVitamine B12 Gerda 1000 µg/4 ml, solution injectable (IM) et buvable | — | — | Hématologie, Hépato-gastroentérologie | register ↗ |
| 🇮🇹 Italy | Shortage DOBETIN + 1 more productsTONOCIAN | 2024-12-31 | — | Cessata commercializzazione definitiva Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Cyanocobalamine in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | TONOCIAN | Shortage | 2025-01-17 | — | Problemi produttivi |
| 🇮🇹 IT | DOBETIN | Shortage | 2024-12-31 | — | Cessata commercializzazione definitiva |
| 🇫🇷 FR | Vitamine B12 Delagrange 1000 µg/2 ml, solution injectable (IM) et buva | Limited availability | — | — | Hématologie, Hépato-gastroentérologie |
| 🇫🇷 FR | Vitamine B12 Gerda 1000 µg/4 ml, solution injectable (IM) et buvable | Limited availability | — | — | Hépato-gastroentérologie |
Yes. As of 8 September 2026, availability issues are reported in: France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Cyanocobalamine: ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Cyanocobalamine — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cyanocobalamine/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Cyanocobalamine availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/cyanocobalamine/">Cyanocobalamine shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>